Overview Retatrutide is a investigational triple-agonist peptide used in metabolic research to examine activity across GLP-1, GIP, and glucagon receptor pathways.
Research Focus Laboratory use focuses on multi-agonist receptor models, signaling integration, and incretin-related biochemical processes.
Mechanism of Interest Its triple-agonist profile supports research into receptor crosstalk, intracellular signal transduction, and metabolic pathway mapping.
Compliance Notice For research only. Not for human consumption.

